Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.0948
+0.0048 (5.33%)
May 17, 2024, 3:55 PM EDT - Market closed

Nascent Biotech Market Cap

Nascent Biotech has a market cap or net worth of $16.09 million as of May 17, 2024. Its market cap has increased by 90.66% in one year.

Market Cap
16.09M
Enterprise Value
15.59M
1-Year Change
90.66%
Ranking
n/a
Category
Stock Price
$0.09

Market Cap Chart

Since May 20, 2019, Nascent Biotech's market cap has increased from $6.24M to $16.09M, an increase of 157.76%. That is a compound annual growth rate of 20.86%.

History

DateMarket Cap% Change
May 17, 202415.45M2.67%
May 16, 202415.05M-7.77%
May 15, 202416.32M-1.93%
May 13, 202416.64M-0.30%
May 10, 202416.69M-
May 9, 202416.69M0.81%
May 8, 202416.56M0.68%
May 7, 202416.45M-1.47%
May 6, 202416.69M-
May 2, 202416.69M2.89%
May 1, 202416.22M-2.90%
Apr 30, 202416.71M-
Apr 29, 202416.71M-
Apr 24, 202416.71M17.16%
Apr 23, 202414.26M-5.10%
Apr 22, 202415.03M-4.02%
Apr 19, 202415.66M1.36%
Apr 18, 202415.45M-3.30%
Apr 16, 202415.97M-20.22%
Apr 15, 202420.02M8.97%
Apr 12, 202418.37M23.43%
Apr 11, 202414.88M0.23%
Apr 10, 202414.85M-
Apr 9, 202414.85M4.78%
Apr 8, 202414.17M-29.38%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 747.99B
Novo Nordisk 572.04B
UnitedHealth Group 476.19B
Johnson & Johnson 367.43B
Merck & Co. 333.65B
AbbVie 289.23B
AstraZeneca 238.64B
Thermo Fisher 228.66B
Market Cap Rankings